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PATTERNS IN WORKING DAYS LOST BY PARENTS OF CHILDREN NEWLY-
DIAGNOSED WITH TYPE 1 DIABETES (T1D). 
Ridyard CH1, Blair J2, Hughes DA1, on behalf of the SCIPI Trial Investigators .3 
1Bangor University, Bangor, United Kingdom, 2Alder Hey Children's NHS Foundation Trust, Liverpool, United 
Kingdom, 3Clinical Trials Research Centre, Liverpool, United Kingdom 
OBJECTIVES: Continuous subcutaneous insulin infusions (CSII) are an alternative to multiple daily injections 
(MDI) for glycaemic control and reducing the risk of developing long term microvascular and macrovascular 
complications in type 1 diabetes (T1D). The objective of this study as part of a randomised clinical trial (SCIPI, 
ISRCTN29255275) was to assess patterns of work-related absences, and whether a difference was apparent 
between treatment groups. METHODS: Patients between 7 months and 15 years of age, newly diagnosed with 
T1D were eligible to participate in this pragmatic, open, multicentre, parallel group, randomised, controlled trial. 
Parental work-related absences in days from the preceding 3-months were measured by parental interview at 
randomisation, 3, 6, 9 and 12 month intervals. RESULTS: Actual time taken off work was reported by parents 
and/or guardians for 78% of participants (CSII=113, MDI=117). Absence from work between randomisation and 
12-month follow-up in parents of patients in the CSII group was 3.6 days (95% CI 2.3, 4.9) compared to 2.7 days 
(1.9 to 3.4) in the MDI group [difference in means of 0.9 days (95% CI -0.6, 2.5)]. In the 3-month period prior to 
randomisation, however, absence from work in parents of patients in the CSII group was 5.5 days (95% CI 4.7, 
6.3) compared to 4.9 days (4.1 to 5.7) in the MDI group [difference in means of 0.6 days (95% CI -0.5, 
1.7)]. CONCLUSIONS: T1D diagnosis for a child can have a temporary disruptive influence on parental work 
commitments. However, there is no evidence to suggest that one treatment is associated with any more or less 
work-related absences than the other. 
 
